| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |